The AstraZeneca Exclusive – The Secret to Securing 94% Payment on Time and Still Optimising Working Capital
Webinar > 06/29/2010
Invoice & Payment
You often hear stories about companies boosting working capital, but later you find that they are some of the worst payers in the industry! The lessons learnt from the days of the economic downturn was that multi-nationals have a responsibility to their suppliers – to help keep them in business. So the importance of the Payment on Time metric has seen a particular rise in the last 24 months.
Now Payment on Time is a reflection of how efficient your purchase to pay process is, and provides a meaningful assessment of the health of your process. In this truly excellent webinar, pharmaceuticals giant AstraZeneca will share with you how they have applied certain tools within their purchase to pay process to ensure that 94% of their transactions are paid on time. But these gains in Payment on Time have not come at the cost of optimising working capital and this 60-minute session will explain how AstraZeneca achieved both objectives.
Join us today to find out how AstraZeneca:
Improved their Payment on Time performance from 74% to 94%
Communicated change to the business to ensure process users followed rules and changed behaviour
Improved their working capital position in spite of their Payment on Time results
Achieved 60% touchless processing of invoices in the first phase of implementation
Significantly reduced their processing cost per invoice
If process efficiency in purchase to pay or optimising working capital are among your priorities this year, you'll want to attend this informative webinar.
Speakers:
James Tucker – Director of Product Marketing, Ariba Financial Solutions and Network Solutions
